In this report, we summarize the findings of 10 phase 3 and 4 clinical studies evaluating coadministration of the quadrivalent meningococcal ... vaccine interactions. Furthermore, 5 studies (2 ...

A life-saving meningococcal vaccine covering all five common strains of the deadly disease could soon be available thanks to ...

Based on type, conjugate vaccines ... for a dominant 60.1% of the global meningococcal vaccines market share in 2025. • By age group, children and adults (2 years & above) segment is set to ...

The ACIP voted that Penmenvy may be used as part of the adolescent meningococcal vaccination schedule as ... Penmenvy is administered intramuscularly as 2 doses 6 months apart.

Stay updated on the latest vaccination recommendations to know when and how to get vaccinated. Meningococcal disease is an infection caused by Neisseria meningitidis, a type of meningococcal ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

and meningococcal serogroup B (MenB) vaccines separately during the same visit, usually at age 16. Adopting this treatment approach could sharply cut the number of injections needed, likely ...

A doctor needs to perform tests to determine which type you have ... infections that can cause meningitis. The meningococcal conjugate, or MenACWY vaccine (often called by brand names such ...

2 In another vote, ACIP recommended Penmenvy as an alternative to separate meningococcal group ACWY and meningococcal group B (MenB) vaccinations when both are administered during the same visit for ...

This recommendation, if adopted, will allow for vaccination against serogroups A, B, C, W, and Y in fewer doses, could simplify meningococcal vaccination delivery and could improve immunization ...